JP2023516004A5 - - Google Patents
Info
- Publication number
- JP2023516004A5 JP2023516004A5 JP2022551742A JP2022551742A JP2023516004A5 JP 2023516004 A5 JP2023516004 A5 JP 2023516004A5 JP 2022551742 A JP2022551742 A JP 2022551742A JP 2022551742 A JP2022551742 A JP 2022551742A JP 2023516004 A5 JP2023516004 A5 JP 2023516004A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr1
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020077148 | 2020-02-28 | ||
| CNPCT/CN2020/077148 | 2020-02-28 | ||
| PCT/CN2021/078051 WO2021170068A1 (en) | 2020-02-28 | 2021-02-26 | Anti-cd137 constructs, multispecific antibody and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023516004A JP2023516004A (ja) | 2023-04-17 |
| JP2023516004A5 true JP2023516004A5 (https=) | 2024-02-27 |
| JP7702961B2 JP7702961B2 (ja) | 2025-07-04 |
| JP7702961B6 JP7702961B6 (ja) | 2025-07-17 |
Family
ID=77489868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551742A Active JP7702961B6 (ja) | 2020-02-28 | 2021-02-26 | 抗ｃｄ１３７コンストラクト、多重特異性抗体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230067770A1 (https=) |
| EP (1) | EP4110827A4 (https=) |
| JP (1) | JP7702961B6 (https=) |
| KR (1) | KR20220148228A (https=) |
| CN (1) | CN115190889A (https=) |
| AU (1) | AU2021228077A1 (https=) |
| CA (1) | CA3169943A1 (https=) |
| WO (1) | WO2021170068A1 (https=) |
| ZA (1) | ZA202210626B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114450306B (zh) * | 2019-07-26 | 2024-04-05 | Abl生物公司 | 抗egfr/抗4-1bb双特异性抗体及其用途 |
| AU2022260298A1 (en) * | 2021-04-23 | 2023-11-02 | Shanghai Henlius Biotech, Inc. | Anti-gpc3 antibodies, multispecific antibodies and methods of use |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025101526A1 (en) * | 2023-11-06 | 2025-05-15 | Beijing Starmab Biomed Technology Ltd | Multi-specific cancer-targeting antibodies |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| WO2026037257A1 (en) * | 2024-08-12 | 2026-02-19 | Shanghai Henlius Biotech, Inc. | Anti-egfr/met multispecific antibodies and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7288638B2 (en) * | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| MX337040B (es) * | 2010-09-09 | 2016-02-09 | Pfizer | Moleculas de union a 4-1bb. |
| EP3613433B1 (en) * | 2014-05-30 | 2022-01-05 | Shanghai Henlius Biotech, Inc. | Anti-epidermal growth factor receptor (egfr) antibodies |
| EP3445788B1 (en) * | 2016-04-22 | 2022-01-19 | Alligator Bioscience AB | Novel bispecific polypeptides against cd137 |
| WO2018031258A1 (en) * | 2016-08-12 | 2018-02-15 | Janssen Biotech, Inc. | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions |
| EP3470428A1 (en) * | 2017-10-10 | 2019-04-17 | Numab Innovation AG | Antibodies targeting cd137 and methods of use thereof |
-
2021
- 2021-02-26 JP JP2022551742A patent/JP7702961B6/ja active Active
- 2021-02-26 WO PCT/CN2021/078051 patent/WO2021170068A1/en not_active Ceased
- 2021-02-26 EP EP21761044.3A patent/EP4110827A4/en active Pending
- 2021-02-26 KR KR1020227033169A patent/KR20220148228A/ko active Pending
- 2021-02-26 CA CA3169943A patent/CA3169943A1/en active Pending
- 2021-02-26 AU AU2021228077A patent/AU2021228077A1/en active Pending
- 2021-02-26 CN CN202180015561.7A patent/CN115190889A/zh active Pending
-
2022
- 2022-08-26 US US17/822,737 patent/US20230067770A1/en active Pending
- 2022-09-26 ZA ZA2022/10626A patent/ZA202210626B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516004A5 (https=) | ||
| JP2023509448A5 (https=) | ||
| CN102369214B (zh) | 三价、双特异性抗体 | |
| JP2023516941A5 (https=) | ||
| JP2023543031A5 (https=) | ||
| JP2021098733A5 (https=) | ||
| US20220002398A1 (en) | ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENT | |
| TWI874613B (zh) | 微型導引和導航控制(miniGNC)類抗體蛋白及其製造和使用方法 | |
| JP2021510521A5 (https=) | ||
| JP2020533311A5 (ja) | ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質 | |
| RU2021110369A (ru) | Белки, связывающие nkg2d, cd16 и опухолеассоциированный антиген | |
| JP2018526981A5 (https=) | ||
| MX2011010159A (es) | Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla. | |
| WO2010112194A1 (en) | Antigen-binding polypeptides and multispecific antibodies comprising them | |
| JP2021533159A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2024504390A5 (https=) | ||
| JP2023529842A5 (https=) | ||
| JP2023549537A5 (https=) | ||
| JP2023536461A5 (https=) | ||
| JP2024532489A5 (https=) | ||
| JP2020502233A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP2023511376A5 (https=) | ||
| JP2025511288A (ja) | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 |